Skip to content
2000
Volume 25, Issue 6
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Introduction

We present an unusual case of a 28-year-old rheumatologic male patient who developed eosinophilia while he was on etanercept therapy previously and then on golimumab.

Case Representation

Although eosinophilia is rarely reported in the literature as a side-effect of various Tumor Necrosis Factor-alpha (TNF-alpha) antagonists, it represents a riddle about the future treatments of these patients since the persistence of therapy might lead to the onset of dermatologic or visceral eosinophilic complications in such patients.

Conclusion

Furthermore, the pathogenesis of eosinophilia is still unknown, and all the proposed hypotheses do not explain the eosinophilic proliferation in certain subjects.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303309437240703114340
2024-07-22
2025-05-30
Loading full text...

Full text loading...

References

  1. CessakG. KuzawińskaO. BurdaA. LisK. WojnarM. Mirowska-GuzelD. Bałkowiec-IskraE. TNF inhibitors: Mechanisms of action, approved and off-label indications.Pharmacol. Rep.201466583684410.1016/j.pharep.2014.05.004 25149988
    [Google Scholar]
  2. BhandariS. BaralM.R. BarberyM. RudinskayaA. SostinO. Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: A review of the current evidence.Ann. Hematol.202210191897190410.1007/s00277‑022‑04896‑7 35759025
    [Google Scholar]
  3. GuidelliG. TentiS. FioravantiA. Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis.Indian J. Dermatol. Venereol. Leprol.201480218718910.4103/0378‑6323.129422 24685874
    [Google Scholar]
  4. HeJ. LuoJ. YangQ. YuanF. Eosinophilia in a patient with ankylosing spondylitis treated with prolonged adalimumab only.Arch. Med. Sci.202218256456710.5114/aoms/146793 35316919
    [Google Scholar]
  5. ChiriacA. BrzezinskiP. StolnicuS. PodoleanuC. MoldovanC. MolnarC. TaranuT. Eosinophilia – A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis.J. Dermatolog. Treat.201627211011310.3109/09546634.2015.1079299 26292921
    [Google Scholar]
  6. MalisiewiczB. MurerC. Pachlopnik SchmidJ. FrenchL.E. Schmid-GrendelmeierP. NavariniA.A. Eosinophilia during psoriasis treatment with TNF antagonists.Dermatology2011223431131510.1159/000334805 22301393
    [Google Scholar]
  7. AzumaN. MatsuiK. HashimotoN. YoshikawaT. SanoH. Successful switch to golimumab for eosinophilia and skin symptoms related to multiple biologics in a patient with rheumatoid arthritis.Intern. Med.201756121585159010.2169/internalmedicine.56.8168 28626189
    [Google Scholar]
  8. DabasG. DeD. HandaS. ChatterjeeD. Wells syndrome in a patient receiving adalimumab biosimilar: a case report and review of literature.Indian J. Dermatol. Venereol. Leprol.201884559459910.4103/ijdvl.IJDVL_636_1
    [Google Scholar]
  9. NakahigashiK. EgawaG. MiyachiY. KabashimaK. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.Acta Derm. Venereol.201494223924010.2340/00015555‑1662
    [Google Scholar]
  10. CancelliereN. BarrancoP. VidaurrázagaC. BenitoD.M. Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept.J. Investig. Allergol. Clin. Immunol.201121248249
    [Google Scholar]
  11. WangG. ZhuoN. WenZ. Eosinophilic fasciitis induced by certolizumab pegol: association or coincidence?Clin. Exp. Rheumatol.2023135917410.55563/clinexprheumatol/am8x3p
    [Google Scholar]
  12. BassiA. PiccoloV. GinoriA. GallippiG. MazzatentaC. Eosinophilic annular erythema due to certolizumab pegol therapy for rheumatoid arthritis post-COVID-19 vaccine.Dermatol. Pract. Concept.2023132e202309510.5826/dpc.1302a95 37196288
    [Google Scholar]
  13. RubinD.T. SohiS. ShillingR.A. WhiteS.R. Pulmonary eosinophilia following infliximab treatment for crohn’s disease.Gastroenterol. Hepatol. (N. Y.)200628592596 28316528
    [Google Scholar]
  14. HussainN. PatelP. YinJ. DavisR. IkladiosO. A case of Loeffler’s endocarditis after initiation of adalimumab.J. Community Hosp. Intern. Med. Perspect.201991293210.1080/20009666.2018.1562852 30788072
    [Google Scholar]
  15. AdamsonR. YaziciY. KatzE.S. GreismanS.G. SteigerD. Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis.J. Clin. Rheumatol.201319738638910.1097/RHU.0b013e3182a701cb 24048108
    [Google Scholar]
  16. MuirA. SurreyL. KriegermeierA. ShaikhkalilA. PiccoliD.A. 16)Muir A, Surrey L, Kriegermeier A, Shaikhkalil A, Piccoli DA. Severe eosinophilic gastroenteritis in a Crohn’s disease patient treated with infliximab and adalimumab.Am. J. Gastroenterol.2016111343743810.1038/ajg.2015.438
    [Google Scholar]
  17. SarginG. SenturkT. YavasogluI. The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-α inhibitors.Saudi Pharm. J.201826794394610.1016/j.jsps.2018.05.001 30416349
    [Google Scholar]
  18. VesterK. RügerR.D. HarthW. SimonJ.C. Transient blood eosinophilia during treatment with Adalimumab.J. Eur. Acad. Dermatol. Venereol.201226792492510.1111/j.1468‑3083.2011.04169.x 21718365
    [Google Scholar]
  19. GigonL. FettreletT. YousefiS. SimonD. SimonH.U. Eosinophils from A to Z.Allergy20237871810184610.1111/all.15751 37102676
    [Google Scholar]
  20. EmmanuelD. ParijaS.C. JainA. MisraD.P. KarR. NegiV.S. Persistent eosinophilia in rheumatoid arthritis: A prospective observational study.Rheumatol. Int.201939224525310.1007/s00296‑018‑4191‑1 30426234
    [Google Scholar]
  21. MorrisroeK. WongM. Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis.Rheumatology201554112113211410.1093/rheumatology/kev275 26224305
    [Google Scholar]
  22. NadeemI. KhatanaU. RasoolM.U. Lessons of the month 2: Chronic eosinophilic pneumonia (CEP): a rare manifestation of infliximab therapy.Clin. Med. 202050443543710.7861/clinmed.2020‑0271
    [Google Scholar]
/content/journals/emiddt/10.2174/0118715303309437240703114340
Loading
/content/journals/emiddt/10.2174/0118715303309437240703114340
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test